Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Minoxidil with betamethasone is the most effective for hair regrowth in alopecia areata.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

COVID-19 vaccines do not increase the risk of alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Thuja orientalis L. has many health benefits and could be used in new medicines.

Topical tofacitinib is effective and safe for treating alopecia areata.

Angelica Sinensis and Chinese Arborvitae have various medicinal benefits, including anti-inflammatory and anti-cancer effects.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Get3d protein helps maintain photosynthesis in plants and photosynthetic bacteria.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.